Archive | Melanoma In The News

Nivolumab Shows Benefit After Progression in Advanced Melanoma

Treatment of advanced melanoma with the checkpoint inhibitor nivolumab beyond RECIST-defined progression resulted in clinical benefit for selected patients, according to pooled, retrospective data from two phase III trials.

Read the full story

Posted in Melanoma In The News, Clinical Trials

Vela HIV, Melanoma Assays Secure Regulatory Approvals

NEW YORK (GenomeWeb) – Vela Diagnostics announced today that it has received regulatory approval for its Sentosa SQ HIV genotyping assay in Australia and its Sentosa SQ melanoma panel in Singapore.

Read the full story

Posted in Melanoma In The News, Information

AMA grants procedure codes for pigmented lesion assay for melanoma

DermTech has reported that the AMA has granted the company category 1, tier 2 molecular pathology procedure codes related to its proprietary test for the detection of melanoma-related gene expression.

Read the full story

Posted in Melanoma In The News, Clinical Trials

Lithium May Reduce Melanoma Risk and Mortality

Laboratory studies show lithium, an activator of  the Wnt/ß-catenin signaling pathway, slows melanoma progression, but no published epidemiologic studies have explored this association.

Read the full story

Posted in Melanoma In The News, Information

Melanoma Google Alerts

Melanoma Google Alerts is a summary of daily articles found in print and on the internet. The articles do not necessarily represent the views of Melbourne Melanoma Project

News Archives

News Categories